Evozyne
Signal active
Organization
Contact Information
Overview
Evozyne is a generative AI company that focuses on therapeutic discovery and drug development. It is a biotechnology company that specializes in protein design and molecular scale. Its mission is to unlock the potential of novel proteins to solve complex human and societal challenges by revolutionizing protein design.
It was founded in 2020 and is headquartered in Chicago, Illinois.
About
Industries
Biotechnology, Artificial Intelligence (AI), Life Science, Medical, Therapeutics
Founded
2020
Employees
51-100
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Evozyne headquartered in United States, North America, operates in the Biotechnology, Artificial Intelligence (AI), Life Science, Medical, Therapeutics sector. The company focuses on Biotechnology and has secured $8.7B in funding across 60 round(s). With a team of 51-100 employees, Evozyne is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Evozyne, raised $81.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
5
Lead Investors
0
Total Funding Amount
$144.4M
Details
1
Evozyne has raised a total of $144.4M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Early Stage Venture | 81.0M |
Investors
Evozyne is funded by 7 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| OrbiMed | - | FUNDING ROUND - OrbiMed | 81.0M |
| NVentures | - | FUNDING ROUND - NVentures | 81.0M |
| Evozyne | - | FUNDING ROUND - Evozyne | 81.0M |
| Valor Equity Partners | - | FUNDING ROUND - Valor Equity Partners | 81.0M |
Recent Activity
There is no recent news or activity for this profile.